APHROZONE, CO., LTD. – Trademark Portfolio

Entity Type: 03

APHROZONE, CO., LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CEVIANGS and RUBY-CELL. The owner is based in Seoul.

130-29 NonHyeon-Dong, Gangnam-Gu

Seoul , KR

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

APHROZONE, CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (3 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does APHROZONE, CO., LTD. have?

APHROZONE, CO., LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.

What trademark classes does APHROZONE, CO., LTD. file in?

APHROZONE, CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are APHROZONE, CO., LTD.'s most well-known trademarks?

APHROZONE, CO., LTD.'s registered trademark portfolio includes well-known marks such as CEVIANGS and RUBY-CELL. These are among 2 currently registered trademarks in the portfolio.

What is APHROZONE, CO., LTD.'s trademark registration success rate?

APHROZONE, CO., LTD. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.